Efficacy and Safety Evaluation of Tacrolimus-Eluting Stent in a Porcine Coronary Artery Model.
Dae Sung ParkMi Hyang NaMyung Ho JeongDoo Sun SimYu Jeong JinHae Jin KeeMun Ki KimJeong Ha KimYoung Joon HongKyung Hoon ChoDae Young HyunSeok OhKyung Seob LimDae-Heung ByeonJeong Hun KimPublished in: Tissue engineering and regenerative medicine (2024)
Similar to SES, TES reduces neointimal proliferation in a porcine coronary artery model, specifically decreasing the fibrins score. Therefore, tacrolimus could be considered a promising drug for reducing restenosis and thrombosis.